| Gene symbol | MERTK | Synonyms | MER, RP38, Tyro12, c-Eyk, c-mer | Type of gene | protein-coding |
| Chromosome | 2 | Map location | 2q13 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | MER proto-oncogene, tyrosine kinase | ||||
| GTO ID | GTC0129 |
| Trial ID | NCT01482195 |
| Disease | Retinal Disease |
| Altered gene | MERTK |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | rAAV2-VMD2-hMERTK |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Phase I Trial of Ocular Subretinal Injection of a Recombinant Adeno-Associated Virus (rAAV2-VMD2-hMERTK) Gene Vector to Patients With Retinal Disease Due to MERTK Mutations |
| Year | 2011 |
| Country | Saudi Arabia |
| Company sponsor | King Khaled Eye Specialist Hospital |
| Other ID(s) | 0916-P |
| Vector information | |||||||||||||
|
|||||||||||||
| Cohort 1 | |||||||||||||
|
|||||||||||||